Cancer Precision Diagnosis Firm 3D Medicines Raises RMB280M

This Data Is Locked!

This area is available only to Subscribers.

A Chinese cancer precision diagnostics firm 3D Medicines recently completed a 280 million yuan (US$40 million) financing for its diagnostic business segment. This round of... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?